These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29447028)

  • 1. Elastase as a potential biomarker for radiation-induced gut wall injury of the distal bowel in an experimental mouse model.
    Sjöberg F; Malipatlolla DK; Patel P; Wilderäng U; Kalm M; Steineck G; Bull C
    Acta Oncol; 2018 Aug; 57(8):1025-1030. PubMed ID: 29447028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients.
    Boerlage TC; Westerink F; Poland DC; Huibregtse IL; Acherman YI; Gerdes VE
    Obes Surg; 2016 Dec; 26(12):2974-2980. PubMed ID: 27216731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
    Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.
    Pezzilli R; Barassi A; Morselli-Labate AM; Fantini L; Tomassetti P; Campana D; Casadei R; Finazzi S; d'Eril GM; Corinaldesi R
    J Gastroenterol; 2007 Sep; 42(9):754-60. PubMed ID: 17876545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.
    Kwapisz L; Gregor J; Chande N; Yan B; Ponich T; Mosli M
    Scand J Gastroenterol; 2017 Aug; 52(8):846-850. PubMed ID: 28423962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin in inflammatory bowel diseases: update and perspectives.
    Manceau H; Chicha-Cattoir V; Puy H; Peoc'h K
    Clin Chem Lab Med; 2017 Mar; 55(4):474-483. PubMed ID: 27658156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal calprotectin as a promising marker of inflammatory diseases.
    Paduchova Z; Durackova Z
    Bratisl Lek Listy; 2009; 110(10):598-602. PubMed ID: 20017448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
    Li XG; Lu YM; Gu F; Yang XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O; Naumann M; Shastri Y; Povse N; Stein J
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.
    Fukunaga S; Kuwaki K; Mitsuyama K; Takedatsu H; Yoshioka S; Yamasaki H; Yamauchi R; Mori A; Kakuma T; Tsuruta O; Torimura T
    Int J Mol Med; 2018 Jan; 41(1):107-118. PubMed ID: 29115397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
    Grad C; David L; Portincasa P; Dumitraşcu DL
    Rom J Intern Med; 2012; 50(1):3-6. PubMed ID: 22788087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
    Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
    Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.
    Otten CM; Kok L; Witteman BJ; Baumgarten R; Kampman E; Moons KG; de Wit NJ
    Clin Chem Lab Med; 2008; 46(9):1275-80. PubMed ID: 18597588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.